P

Inventor

WU TONGFEI

BE29 patents
⚠️ This page may combine multiple inventors who share the name “WU TONGFEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN PHARMACEUTICA NV

15 patents
US11059850B2Jul 13, 2021

Spirobicyclic analogues

JANSSEN PHARMACEUTICA NV8 citations81
US10653711B2May 19, 2020

6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors

JANSSEN PHARMACEUTICA NV6 citations81
US10888550B2Jan 12, 2021

Pyrazole derivatives as MALT1 inhibitors

JANSSEN PHARMACEUTICA NV3 citations71
US11702441B2Jul 18, 2023

Spirobicyclic analogues

JANSSEN PHARMACEUTICA NV2 citations70
US11318157B2May 3, 2022

6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors

JANSSEN PHARMACEUTICA NV1 citations70
US10954214B2Mar 23, 2021

Pyrazole derivatives as MALT1 inhibitors

JANSSEN PHARMACEUTICA NV5 citations69
US11883367B2Jan 30, 2024

6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors

JANSSEN PHARMACEUTICA NV0 citations60
US11040031B2Jun 22, 2021

Pyrazole derivatives as MALT1 inhibitors

JANSSEN PHARMACEUTICA NV2 citations60
US12145961B2Nov 19, 2024

Spirobicyclic analogues

JANSSEN PHARMACEUTICA NV0 citations59
US12077521B2Sep 3, 2024

Pyrazole derivatives as MALT1 inhibitors

JANSSEN PHARMACEUTICA NV0 citations59
US11993614B2May 28, 2024

Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors

JANSSEN PHARMACEUTICA NV0 citations59
US11098062B2Aug 24, 2021

Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors

JANSSEN PHARMACEUTICA NV0 citations59
US12404260B2Sep 2, 2025

Pyridine rings containing derivatives as MALT1 inhibitors

JANSSEN PHARMACEUTICA NV0 citations47
US10898504B2Jan 26, 2021

Substituted nucleoside analogues for use as PRMT5 inhibitors

JANSSEN PHARMACEUTICA NV0 citations47
US11571437B2Feb 7, 2023

Methods of treating cancer using PRMT5 inhibitors

JANSSEN PHARMACEUTICA NV0 citations39

ALIGOS THERAPEUTICS INC

5 patents

LEUVEN K U RES & DEV

3 patents

HERDEWIJN PIET

2 patents

WU TONGFEI

2 patents

GIJSEN HENRICUS JACOBUS MARIA

1 patent

ROMBOUTS FREDERIK JAN RITA

1 patent